2 doses 400 microgram misoprostol
Drug2 doses 400 microgram misoprostol, 3 and 1 hours
NCT Number: NCT02154932
Introduction: The study aimed to investigate the effectiveness of a single versus double dose of Prostaglandin E2 "Misoprostol, 400 microgram" during myomectomy for multiple uterine fibroids. This was a prospective randomized controlled trial comprised of 69 patients with multiple myomas undergoing myomectomy. Patients randomly allocated to either an intra-vaginal single dose of 400 microgram Misoprostol 1 hour pre-operatively (group A, 34 cases) or 2 doses, 3 and 1 hours, prior surgery (group B, 35 cases). Operation time, intra and post-operative blood loss, hemoglobin concentration, blood pressure and body's temperature were estimated and compared in both groups.
Looking for future studies?
Notify Me20 year–50 year
Female
Interventional
Phase 4
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
2 doses 400 microgram misoprostol, 3 and 1 hours
1 dose, 1 hours, prior surgery
Time frame: from skin to skin in minutes
The time from start till end of surgery
Time frame: during and 6 hours after surgery
collected soaked towels and sucked blood
Mansoura University
Other
Single Versus Double Dose Intra-vaginal Prostaglandin E2 "Misoprostol" Prior Abdominal Myomectomy: A Randomized Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.